Revive Therapeutics Ltd. announced that Yanlin Wang, M.D., Ph.D., will join the Company as a Scientific Advisor for cannabinoid-based therapeutics targeting kidney diseases. Dr. Yanlin Wang is an Associate Professor of Medicine and Director of Basic Research in the Selzman Institute for Kidney Health and Section of Nephrology of the Department of Medicine at Baylor College of Medicine. He is board certified by the American Board of Internal Medicine in Internal Medicine and Nephrology and is a Fellow of the American Society of Nephrology. Dr. Wang is an active clinician; he regularly treats patients with kidney diseases at Baylor affiliated hospitals and teaches medical students, residents, and fellows at Baylor College of Medicine. Dr. Wang is currently serving as an editorial board member for a number of biomedical journals.